Journal
PLANTA MEDICA
Volume -, Issue -, Pages -Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/a-2114-0980
Keywords
MET; leukemia; PI3K/Akt/mTOR pathway; Lespedeza bicolor; Fabaceae
Ask authors/readers for more resources
The pharmacological effect of 1-methoxyerythrabyssin II, a compound found in the roots of Lespedeza bicolor, on leukemic cells was evaluated using a network pharmacology strategy. It was found that 1-methoxyerythrabyssin II inhibits cell proliferation in a concentration-dependent manner, with a higher potency against human acute leukemia T cells. The compound induces cell cycle arrest and autophagy, and its mechanism of action involves the inhibition of the PI3K/Akt/mTOR pathway. This discovery provides potential targets for the development of novel therapeutics against leukemia.
Leukemia, despite currently being one of the most lethal cancers worldwide, still lacks a focused treatment. The purpose of the present investigation was to evaluate the pharmacological effect of 1-methoxyerythrabyssin II, a pterocarpan identified in the roots of Lespedeza bicolor , on leukemic cells and to explore its underlying mechanism using a network pharmacology strategy. 1-Methoxyerythrabyssin II showed an antiproliferative effect in a concentration-dependent manner and exhibited a higher potency in human acute leukemia T cells (Jurkat). The G1 phase arrest induced by 1-methoxyerythrabyssin II was confirmed using a cell cycle assay, and the downregulation of CDK2 and cyclin D1 was observed using an immunoblot assay. Moreover, 1-methoxyerythrabyssin II-treated cells exhibited higher expression levels of LC3B, Atg-7, and Beclin 1 in addition to an enhanced fluorescence intensity in monodansylcadaverine staining, indicating autophagy induction by 1-methoxyerythrabyssin II. Furthermore, network pharmacology and molecular docking analyses revealed that the PI3K/Akt/mTOR pathway is a potential target of 1-methoxyerythrabyssin II in leukemic cells. In vitro assays further demonstrated that 1-methoxyerythrabyssin II promoted autophagy and suppressed cell proliferation by inhibiting the PI3K/Akt/mTOR pathway in leukemic cells. This discovery will contribute to the development of novel therapeutics and prophylactics against leukemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available